查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1628801

歐洲泡殼包裝：市場佔有率分析、產業趨勢、成長預測（2025-2030）

Europe Blister Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

歐洲泡殼包裝市場預計在預測期內複合年成長率為 6.45%

歐洲吸塑包裝-市場-IMG1

主要亮點

  • 不斷上升的發病率和政府對假藥的嚴格監管正在增加製藥公司生產藥品的壓力。泡殼包裝為鈔票認證系統等防偽系統提供了有效的方法。
  • 英國製藥業是該國研究和創新領域的主要企業之一。該行業在研發上花費了數十億美元，並僱用了大量高技能的研發工作。英國製藥工業協會 (ABPI) 的數據顯示，在製藥業直接就業的 73,000 名員工中，有 23,000 人從事研發工作。
  • 大量的投資和技術純熟勞工率表明英國正在如何建立藥品和未來藥品的管道。這些持續的投資預計將為該國泡殼包裝的成長提供巨大的機會。
  • 由於其在整個供應鏈中提供個人安全的潛力，泡殼中擴大使用創新技術，例如在包裝外部貼上標籤的 RFID（無線射頻識別標籤）。只有在僅分配一顆膠囊或錠劑或保護屏障被破壞並施用時，才會發生泡殼中樣品的污染。
  • 此外，這次疫情爆發也引發了世界各地針對 COVID-19 疫苗開發的研究。例如，醫療保健巨頭強生公司於 2020 年 9 月開始臨床試驗，並透過美國衛生與公共服務部獲得了約 5 億美元的合作資金。
  • 匹茲堡大學和休士頓貝勒醫學院的研究人員開發的一種實驗性疫苗也在等待食品藥物管理局的批准，開始在人體中進行測試。如果研究人員開發的這些疫苗成功，就可以大規模生產，這可能會進一步增加對液體瓶的需求。

歐洲泡殼包裝市場趨勢

藥品預計將顯著成長

  • 製藥業對泡殼包裝解決方案提出了多種要求，包括與外部環境隔離、成本效益、高防護性、易於處理以及保存藥效等。這些包裝特別適合滿足嚴格的法規，並因其保護性能、成本效益、適應性以及製藥和包裝行業的需求而受到重視。
  • 當藥物採用泡殼包裝時，消費者知道他們的藥物和劑量，從而提高用藥依從性。泡殼的單位劑量特徵降低了錯誤劑量的風險。
  • 零售層面的處方藥製備對於製藥技術人員和藥劑師來說是一個挑戰。在超級市場和藥局的開放環境中給藥可能會對敏感藥物在容器之間轉移時產生不利影響。泡殼包裝可以確保直接配送給客戶的過程。
  • 雖然保護產品完整性仍然是藥品包裝的首要目標，但包裝產業的所有領域都在繼續努力降低包裝過程中的成本。例如，Amcor 的 Polybar 阻隔薄膜系列涵蓋廣泛的防潮阻隔性，具有出色的抗壓性能，可確保為錠劑和膠囊等製藥應用提供最佳保護。我們使用 Aclar、COC、PE、PVC 和 PVdc 等材料。
  • 此外，COVID-19 的爆發擴大了泡殼包裝的市場。 2019年10月，烏克蘭製藥公司Darnitsa通過了COVID-19治療通訊協定中實驗藥物的國家註冊。
  • 該地區多個國家已禁止出口已顯示有效對抗冠狀病毒感染的藥品，首先滿足國內需求非常重要。 Darnica 製藥公司已通過了羥氯喹是一種包含在 COVID-19 治療方案中的實驗藥物。

獨立國協國家預計將顯著成長

  • 在獨立國協國家中，俄羅斯預計將佔有很大佔有率。身為獨立國協（CIS）成員，俄羅斯製藥業是智慧財產權（IP）管理最複雜的產業之一。
  • 俄羅斯的藥品生產正在顯著成長。據俄羅斯工貿部透露，俄羅斯政府預計2020年國內藥品產量將增加20%，並在俄羅斯政府負責醫藥產業的發展。
  • 該部長表示，預期成長與 2020 年前四個月的成長相當，主要是由於該國多個新生產設施的試運行。
  • 然而，俄羅斯政府制定了新策略，即「製藥2030」國家計劃，預計製藥業將出現正面趨勢。莫斯科地區發展公司 (MRDC) 文件描述了過去 10 年的成就、對新項目的期望以及有前景的醫藥投資領域和地點。
  • 此外，據MRDC稱，近期俄羅斯將開始實施醫藥工業發展國家戰略「Pharma 2030」。該戰略為重點產業提供了方向，國家支持機制將刺激重點產業的發展。
  • 國家「醫藥2020」計畫有力地推動了醫療和製藥業的發展，特別是在實施初期。行業相關人員可以期待新的國家計劃的良好開端，這些計劃預計將促進獨立國協地區的市場成長。

歐洲泡殼包裝產業概況

歐洲泡殼包裝市場較為分散。夥伴關係、併購和收購已成為市場上供應商生產最終用戶行業可接受的產品的重要策略，其中包裝材料經過嚴格的品質測試，以確保它們不會污染內容物並影響健康。維持原料的持續流動仍是促進夥伴關係的挑戰。市場主要參與者包括Amcor Ltd、Westrock Company、Sonoco Products Company、Constantia Flexibles GmbH、Honeywell International Inc.等。

  • 2021 年 4 月 - Amcor 宣布對可回收聚乙烯基熱成型泡殼包裝進行客戶試驗。這種新包裝旨在滿足高度專業化和監管的藥品包裝的嚴格要求，為最受歡迎的醫療保健包裝類型創造更永續的選擇。與市場上的替代包裝相比，這項創新還可以減少高達 70% 的碳足跡。
  • 2021 年 7 月 -Honeywell與主要企業的技術主導醫療保健改善公司 Premier 宣佈建立新的商業關係，重點擴大國內丁腈檢查手套的生產。新的合作夥伴關係預計僅第一年就將生產至少 7.5 億隻國產丁腈檢查手套。

其他好處：

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

目錄

第1章簡介

  • 研究假設和市場定義
  • 調查範圍

第2章調查方法

第3章執行摘要

第4章市場洞察

  • 市場概況
  • 市場促進因素
    • 老年人口增加和疾病傳播
    • 產品創新，例如相對便宜的小型化
  • 市場挑戰
    • 法規的動態性和缺乏處理重負載的能力
  • 產業吸引力－波特五力分析
    • 供應商的議價能力
    • 消費者議價能力
    • 新進入者的威脅
    • 競爭公司之間的敵對關係
    • 替代品的威脅
  • 評估 COVID-19 對泡殼包裝市場的影響

第5章歐洲泡殼包裝市場區隔

  • 按流程
    • 熱成型
    • 冷成型
  • 按材質
    • 塑膠薄膜
    • 紙板
    • 鋁
    • 其他材料
  • 按最終用戶產業
    • 消費品
    • 藥品
    • 工業的
    • 其他最終用戶產業
  • 按國家/地區
    • 獨立國協國家
    • 英國
    • 德國
    • 法國
    • 其他歐洲國家

第6章 競爭狀況

  • 公司簡介
    • Amcor PLC
    • Westrock Company
    • Constantia Flexibles GmbH
    • Sonoco Products Company
    • Klockner Pentaplast Group
    • EI Du Pont De Nemours and Company
    • Honeywell International Inc.
    • The Dow Chemical Company
    • Tekni-Plex Inc.

第7章 投資分析

第8章市場的未來

簡介目錄
Product Code: 54578

The Europe Blister Packaging Market is expected to register a CAGR of 6.45% during the forecast period.

Europe Blister Packaging - Market - IMG1

Key Highlights

  • Growing pressure on pharmaceutical companies to manufacture medicines that are different in packaging and hard to imitate, surpassing the basic need of keeping it useful for the purpose it was produced, for it to be made available for patients, due to growth in diseases and stringent government regulations against counterfeit drugs, are among the significant factors propelling the market. Blister packaging provides an efficient method of anti-counterfeit systems, like banknote authentication systems and others.
  • The UK pharmaceutical industry is one of the major players in the research and innovation of the country. The industry contributes billions on R&D and employs vast numbers for highly-skilled R&D roles. According to the Association of the British Pharmaceutical Industry (ABPI), 23,000 people work in R&D out of 73,000 people employed directly by the pharmaceutical industry.
  • The massive investments and the proportion of skilled workers employed show how Britain is building up the pipeline of medicines and future drugs. These ongoing investments are expected to provide an excellent opportunity for the growth of blister packaging in the country.
  • The use of innovative technologies in blisters, such as RFID (radio frequency identification tags), deployed with a seal applied outside the packaging, is increasing due to the potential to offer individual security throughout supply chains. Contamination of samples in blisters only occurs when a single capsule or tablet is dispensed or administered when the protective barrier is broken.
  • Furthermore, the outbreak has increased the research across the world for developing a vaccine for COVID-19. For instance, the healthcare giant, Johnson & Johnson, started clinical trials in September 2020 and has received a nearly USD 500 million partnership via a US Department of Health and Human Services division.
  • Also, experimental vaccines developed by researchers at the University of Pittsburgh and Baylor College of Medicine in Houston are also waiting for permission from the Food and Drug Administration to begin testing in people. The success of these vaccines developed by the researchers might follow the large-scale manufacture of them, further driving the demand for liquid bottles.

Europe Blister Packaging Market Trends

Pharmaceutical is Expected to Witness a Significant Growth

  • The pharmaceutical sector poses a different set of demands for blister packaging solutions, concerning insulation from external surroundings, cost-effectiveness, high levels of protection, and the ease of handling and retaining the effectiveness of the medicine.These packs are uniquely suited to meet stringent regulations and are highly valued for protective properties, cost-effectiveness, adaptability, and the pharmaceutical and packaging industry's requirements.
  • When medicines are blister packaged, adherence is improved because consumers can keep track of their medications and dosage. The unit dosage feature of blisters reduces the risk of incorrect dosing.
  • The retail-level preparation of prescription drugs is troubling pharmaceutical technicians or pharmacists. The administration of medicines in the open atmosphere of the supermarket and drug store may negatively affect sensitive medicines when they are transferred from container to container. Blister packaging can guarantee the process of distribution directly to the customer.
  • Protecting product integrity continues to be the primary goal of pharmaceutical packaging, but there is continued work on cost reduction in the packaging process in all areas of the packaging industry. For instance, The Polybar barrier films product families provided by Amcor cover a wide range of moisture barriers whilst also providing good crush resistance to ensure the best protection for pharmaceutical applications such as tablets and capsules. It uses materials such as Aclar, COC, PE, PVC, and PVdc, among others.
  • Further, the outbreak of the COVID-19 has increased the market for blister packaging. In October 2019, the Ukrainian pharmaceutical company Darnitsa passed the state registration for an experimental drug in the treatment protocol for COVID-19.
  • A few countries across the region have banned the export of medicines that have shown efficacy in the fight against coronavirus infection, and first and foremost, meet the domestic demand. The Darnitsa pharmaceutical company passed the state registration for hydroxychloroquine substance - an experimental drug that is included in the treatment protocol for COVID-19.

CIS Countries are Expected to WItness SIgnificant Growth

  • Among the CIS countries, Russia is anticipated to hold a significant share. The pharmaceutical industry in Russia, one of the Commonwealth of Independent States (CIS) countries, can be considered one of the most complex sectors when considering the management of the intellectual property (IP), as it involves complicated legal, regulatory, linguistic, and marketing factors.
  • The country has been witnessing significant growth in drug production. According to the Russian Ministry of Industry and Trade, the Russian government expects a 20% growth of domestic drug production in 2020, which is responsible for developing the pharmaceutical industry in the Russian government.
  • According to the Minister, the expected growth will be comparable to that which was observed in the first four months of 2020 and was mainly due to the commissioning of some new production facilities within the country.
  • However, the Russian government has also prepared a new strategy - the state program Pharma 2030, which should get the pharmaceutical sector's positive trends. The past decade's results, the expectations for the new program, and the promising areas and locations for investments in pharmaceuticals are mentioned in the Moscow Region Development Corporation (MRDC) material.
  • And according to MRDC, in the near future, Russia will start implementing the state strategy of pharmaceutical industry development Pharma 2030. The strategy indicates the main industry directions, the growth of which will be stimulated with the help of the state support mechanisms.
  • The state program of the country Pharma 2020 gave a strong impetus for developing the medical and pharmaceutical sectors, particularly at the initial stage of implementation. Industry players can expect a good start from the new state program, which is anticipated to augment the market growth in the CIS region.

Europe Blister Packaging Industry Overview

The market for Europe Blister Packaging Market is moderately fragmented. Partnership, mergers, and acquisitions have been a significant strategy for the vendors in the market for producing acceptable products in the end-user industry, where packaging materials undergo stringent quality tests not to contaminate the contents impact health. Maintaining a continuous flow of raw materials remain a challenge that prompts partnerships. Some of the major players in the market are Amcor Ltd, Westrock Company, Sonoco Products Company, Constantia Flexibles GmbH, Honeywell International Inc., among others.

  • April 2021 - Amcor announced customer trials for the recyclable Polyethylene-based thermoform blister packaging. The new packaging is designed to meet the stringent requirements of highly specialized and regulated pharmaceutical packaging and creates a more sustainable alternative for the most in-demand healthcare packaging type. This innovation also benefits from up to 70% reduction in its carbon footprint when compared to packaging alternatives on the market.
  • July 2021 - Honeywell and Premier Inc., a leading technology-driven healthcare improvement company, announced a new commercial relationship dedicated to expanding the domestic production of nitrile exam gloves. This new collaboration is expected to produce at least 750 million domestically made nitrile exam gloves in the first year alone.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing geriatric population and prevalence of diseases
    • 4.2.2 Product innovations such as downsizing coupled with relatively low costs
  • 4.3 Market Challenges
    • 4.3.1 Dynamic nature of regulations and inability to support heavy goods
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Intensity of Competitive Rivalry
    • 4.4.5 Threat of Substitutes
  • 4.5 Assessment of the impact of COVID-19 on Blister Packaging Market

5 EUROPE BLISTER PACKAGING MARKET SEGMENTATION

  • 5.1 By Process
    • 5.1.1 Thermoforming
    • 5.1.2 Coldforming
  • 5.2 By Material
    • 5.2.1 Plastic Films
    • 5.2.2 Paper and Paperboard
    • 5.2.3 Aluminum
    • 5.2.4 Other Materials
  • 5.3 By End-User Industry
    • 5.3.1 Consumer Goods
    • 5.3.2 Pharmaceutical
    • 5.3.3 Industrial
    • 5.3.4 Other End-user Industries
  • 5.4 By Country
    • 5.4.1 CIS countries
    • 5.4.2 United Kingdom
    • 5.4.3 Germany
    • 5.4.4 France
    • 5.4.5 Rest of Europe

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Amcor PLC
    • 6.1.2 Westrock Company
    • 6.1.3 Constantia Flexibles GmbH
    • 6.1.4 Sonoco Products Company
    • 6.1.5 Klockner Pentaplast Group
    • 6.1.6 E.I. Du Pont De Nemours and Company
    • 6.1.7 Honeywell International Inc.
    • 6.1.8 The Dow Chemical Company
    • 6.1.9 Tekni-Plex Inc.

7 INVESTMENT ANALYSIS

8 FUTURE OF THE MARKET